CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q3 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $250,352 | +6.6% | 3,673 | -2.1% | 0.12% | -9.6% |
| Q4 2023 | $234,938 | +0.2% | 3,753 | -10.1% | 0.14% | -13.9% |
| Q2 2023 | $234,384 | -21.9% | 4,175 | -8.9% | 0.16% | -33.9% |
| Q3 2022 | $300,000 | +5.6% | 4,585 | -1.8% | 0.24% | +0.8% |
| Q2 2022 | $284,000 | -68.0% | 4,667 | -60.2% | 0.24% | -72.7% |
| Q1 2022 | $888,000 | 0.0% | 11,714 | 0.0% | 0.87% | 0.0% |
| Q4 2021 | $888,000 | -43.2% | 11,714 | -16.1% | 0.87% | -40.9% |
| Q3 2021 | $1,563,000 | -22.7% | 13,963 | +11.7% | 1.47% | -22.1% |
| Q2 2021 | $2,023,000 | – | 12,498 | – | 1.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
| Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
| EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
| NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
| ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
| NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
| Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
| Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |